BioMeDevice Ltd. today announced today that it is seeking concerned physicians and tension type headache (TTH) /migraine sufferers to actively participate in a broad-based, physician supervised pilot study program to ascertain the efficacy of the FDA approved gumEase® cryoanesthesia dental device in treating migraine and tension type (TTH) headache pain safely, without drugs and their unwelcome side effects.
